JP MORGAN/CALL/BECTON DICKINSON AND CO./280/0.1/17.01.25 Share Price

Warrant

DE000JL1MHY3

Real-time Bid/Ask 14:19:33 27/06/2024 BST
0.65 EUR / 0.8 EUR -0.68% Intraday chart for JP MORGAN/CALL/BECTON DICKINSON AND CO./280/0.1/17.01.25
Current month+25.86%
1 month+1.39%
Date Price Change
27/06/24 0.64 -12.33%
26/06/24 0.73 -9.88%
25/06/24 0.81 -10.99%
24/06/24 0.91 -8.08%
21/06/24 0.99 +30.26%

Delayed Quote Börse Stuttgart

Last update June 27, 2024 at 08:09 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1MHY
ISINDE000JL1MHY3
Date issued 05/04/2023
Strike 280 $
Maturity 17/01/2025 (204 Days)
Parity 10 : 1
Emission price 2.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.21
Lowest since issue 0.48
Spread 0.15
Spread %18.75%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
231.6 USD
Average target price
279.2 USD
Spread / Average Target
+20.54%
Consensus